SMALLPOX vaccine producer Acambis rallied 4p to 278p today following yesterday's 11% fall on fears that Baxter International may sell its 20% stake. Today Acambis said it had filed a licence agreement with the US Food and Drug Administration for its yellow fever vaccine Arilvax.
Create a FREE account to continue reading
Registration is a free and easy way to support our journalism.
Join our community where you can: comment on stories; sign up to newsletters; enter competitions and access content on our app.
Thank you for registering
Please refresh the page or navigate to another page on the site to be automatically logged in